nodes	percent_of_prediction	percent_of_DWPC	metapath
WF10—MAEA—hematologic cancer	0.801	1	CbGaD
WF10—CD163—Scavenging of heme from plasma—HP—hematologic cancer	0.0114	0.41	CbGpPWpGaD
WF10—CD163—hematopoietic system—hematologic cancer	0.0074	0.115	CbGeAlD
WF10—MAEA—hematopoietic system—hematologic cancer	0.0066	0.103	CbGeAlD
WF10—CD163—gonad—hematologic cancer	0.00563	0.0876	CbGeAlD
WF10—MAEA—gonad—hematologic cancer	0.00502	0.0781	CbGeAlD
WF10—CD163—blood—hematologic cancer	0.0049	0.0763	CbGeAlD
WF10—CD163—bone marrow—hematologic cancer	0.00474	0.0738	CbGeAlD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—HP—hematologic cancer	0.00455	0.164	CbGpPWpGaD
WF10—MAEA—blood—hematologic cancer	0.00437	0.068	CbGeAlD
WF10—CD163—lung—hematologic cancer	0.0043	0.0669	CbGeAlD
WF10—MAEA—bone marrow—hematologic cancer	0.00423	0.0658	CbGeAlD
WF10—CD163—testis—hematologic cancer	0.00406	0.0631	CbGeAlD
WF10—MAEA—lung—hematologic cancer	0.00383	0.0596	CbGeAlD
WF10—MAEA—testis—hematologic cancer	0.00362	0.0563	CbGeAlD
WF10—CD163—Scavenging of heme from plasma—ALB—hematologic cancer	0.00298	0.107	CbGpPWpGaD
WF10—CD163—lymph node—hematologic cancer	0.00294	0.0458	CbGeAlD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—hematologic cancer	0.00283	0.102	CbGpPWpGaD
WF10—Haemolysis—Lenalidomide—hematologic cancer	0.00277	0.0258	CcSEcCtD
WF10—MAEA—lymph node—hematologic cancer	0.00262	0.0408	CbGeAlD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—CALR—hematologic cancer	0.00257	0.0924	CbGpPWpGaD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—HSP90AA1—hematologic cancer	0.00226	0.0815	CbGpPWpGaD
WF10—Fluid overload—Idarubicin—hematologic cancer	0.00206	0.0192	CcSEcCtD
WF10—Lung disorder—Pentostatin—hematologic cancer	0.00188	0.0175	CcSEcCtD
WF10—Haemolysis—Cisplatin—hematologic cancer	0.00186	0.0174	CcSEcCtD
WF10—Fluid overload—Busulfan—hematologic cancer	0.00186	0.0173	CcSEcCtD
WF10—Lung disorder—Busulfan—hematologic cancer	0.00163	0.0152	CcSEcCtD
WF10—Lung disorder—Bexarotene—hematologic cancer	0.00155	0.0145	CcSEcCtD
WF10—Extravasation—Daunorubicin—hematologic cancer	0.00153	0.0143	CcSEcCtD
WF10—Extravasation—Idarubicin—hematologic cancer	0.00147	0.0137	CcSEcCtD
WF10—Extravasation—Teniposide—hematologic cancer	0.00143	0.0133	CcSEcCtD
WF10—Venous thrombosis—Thalidomide—hematologic cancer	0.00135	0.0126	CcSEcCtD
WF10—Extravasation—Busulfan—hematologic cancer	0.00132	0.0123	CcSEcCtD
WF10—Fluid overload—Bortezomib—hematologic cancer	0.0013	0.0121	CcSEcCtD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—ALB—hematologic cancer	0.00119	0.0428	CbGpPWpGaD
WF10—Lung disorder—Bortezomib—hematologic cancer	0.00114	0.0107	CcSEcCtD
WF10—Extravasation—Cladribine—hematologic cancer	0.00114	0.0106	CcSEcCtD
WF10—Phlebitis—Pentostatin—hematologic cancer	0.00112	0.0104	CcSEcCtD
WF10—Fluid overload—Alitretinoin—hematologic cancer	0.00112	0.0104	CcSEcCtD
WF10—Lung disorder—Vinorelbine—hematologic cancer	0.00112	0.0104	CcSEcCtD
WF10—Venous thrombosis—Cisplatin—hematologic cancer	0.0011	0.0102	CcSEcCtD
WF10—Extravasation—Vinblastine—hematologic cancer	0.00109	0.0102	CcSEcCtD
WF10—Phlebitis—Idarubicin—hematologic cancer	0.00108	0.0101	CcSEcCtD
WF10—Phlebitis—Teniposide—hematologic cancer	0.00105	0.00979	CcSEcCtD
WF10—Extravasation—Melphalan—hematologic cancer	0.00104	0.00967	CcSEcCtD
WF10—Lung disorder—Thalidomide—hematologic cancer	0.00103	0.00962	CcSEcCtD
WF10—Lung disorder—Alitretinoin—hematologic cancer	0.000982	0.00915	CcSEcCtD
WF10—Hyponatraemia—Pentostatin—hematologic cancer	0.000969	0.00903	CcSEcCtD
WF10—Fluid overload—Cisplatin—hematologic cancer	0.000952	0.00887	CcSEcCtD
WF10—Extravasation—Bortezomib—hematologic cancer	0.000928	0.00865	CcSEcCtD
WF10—Phlebitis—Fludarabine—hematologic cancer	0.000924	0.00861	CcSEcCtD
WF10—Lung disorder—Irinotecan—hematologic cancer	0.000922	0.00859	CcSEcCtD
WF10—Extravasation—Bleomycin—hematologic cancer	0.000921	0.00858	CcSEcCtD
WF10—Extravasation—Vinorelbine—hematologic cancer	0.000907	0.00844	CcSEcCtD
WF10—Extravasation—Thiotepa—hematologic cancer	0.000866	0.00807	CcSEcCtD
WF10—Hyponatraemia—Busulfan—hematologic cancer	0.000843	0.00785	CcSEcCtD
WF10—Phlebitis—Cladribine—hematologic cancer	0.000836	0.00779	CcSEcCtD
WF10—Infection—Ruxolitinib—hematologic cancer	0.000826	0.0077	CcSEcCtD
WF10—Extravasation—Carmustine—hematologic cancer	0.000804	0.00749	CcSEcCtD
WF10—Phlebitis—Vinblastine—hematologic cancer	0.000802	0.00747	CcSEcCtD
WF10—Hyponatraemia—Bexarotene—hematologic cancer	0.000801	0.00746	CcSEcCtD
WF10—Extravasation—Ifosfamide—hematologic cancer	0.000787	0.00734	CcSEcCtD
WF10—Extravasation—Vincristine—hematologic cancer	0.000768	0.00715	CcSEcCtD
WF10—Extravasation—Mitoxantrone—hematologic cancer	0.000748	0.00696	CcSEcCtD
WF10—Extravasation—Irinotecan—hematologic cancer	0.000748	0.00696	CcSEcCtD
WF10—Hyponatraemia—Nilotinib—hematologic cancer	0.00074	0.0069	CcSEcCtD
WF10—Hyponatraemia—Imatinib—hematologic cancer	0.000736	0.00686	CcSEcCtD
WF10—Extravasation—Gemcitabine—hematologic cancer	0.000728	0.00678	CcSEcCtD
WF10—Infection—Vorinostat—hematologic cancer	0.000698	0.0065	CcSEcCtD
WF10—Phlebitis—Bortezomib—hematologic cancer	0.000683	0.00636	CcSEcCtD
WF10—Extravasation—Cisplatin—hematologic cancer	0.000679	0.00632	CcSEcCtD
WF10—Phlebitis—Bleomycin—hematologic cancer	0.000677	0.00631	CcSEcCtD
WF10—Phlebitis—Vinorelbine—hematologic cancer	0.000666	0.00621	CcSEcCtD
WF10—Hyponatraemia—Melphalan—hematologic cancer	0.00066	0.00615	CcSEcCtD
WF10—Body temperature increased—Ruxolitinib—hematologic cancer	0.000657	0.00612	CcSEcCtD
WF10—Hyponatraemia—Lenalidomide—hematologic cancer	0.000642	0.00598	CcSEcCtD
WF10—Infection—Lomustine—hematologic cancer	0.000626	0.00583	CcSEcCtD
WF10—Extravasation—Etoposide—hematologic cancer	0.000622	0.00579	CcSEcCtD
WF10—Infection—Mechlorethamine—hematologic cancer	0.0006	0.00559	CcSEcCtD
WF10—Phlebitis—Carmustine—hematologic cancer	0.000591	0.00551	CcSEcCtD
WF10—Hyponatraemia—Bortezomib—hematologic cancer	0.00059	0.0055	CcSEcCtD
WF10—Phlebitis—Alitretinoin—hematologic cancer	0.000586	0.00546	CcSEcCtD
WF10—Phlebitis—Ifosfamide—hematologic cancer	0.000579	0.00539	CcSEcCtD
WF10—Hyponatraemia—Vinorelbine—hematologic cancer	0.000576	0.00537	CcSEcCtD
WF10—Venous thrombosis—Epirubicin—hematologic cancer	0.000563	0.00525	CcSEcCtD
WF10—Body temperature increased—Vorinostat—hematologic cancer	0.000556	0.00518	CcSEcCtD
WF10—Phlebitis—Mitoxantrone—hematologic cancer	0.00055	0.00512	CcSEcCtD
WF10—Hyponatraemia—Thalidomide—hematologic cancer	0.000532	0.00496	CcSEcCtD
WF10—Venous thrombosis—Doxorubicin—hematologic cancer	0.000521	0.00486	CcSEcCtD
WF10—Extravasation—Dexamethasone—hematologic cancer	0.000512	0.00477	CcSEcCtD
WF10—Extravasation—Betamethasone—hematologic cancer	0.000512	0.00477	CcSEcCtD
WF10—Hyponatraemia—Carmustine—hematologic cancer	0.000511	0.00476	CcSEcCtD
WF10—Oedema—Nelarabine—hematologic cancer	0.000509	0.00474	CcSEcCtD
WF10—Infection—Nelarabine—hematologic cancer	0.000506	0.00471	CcSEcCtD
WF10—Phlebitis—Cisplatin—hematologic cancer	0.000499	0.00465	CcSEcCtD
WF10—Body temperature increased—Lomustine—hematologic cancer	0.000498	0.00464	CcSEcCtD
WF10—Oedema—Methoxsalen—hematologic cancer	0.000497	0.00463	CcSEcCtD
WF10—Infection—Methoxsalen—hematologic cancer	0.000494	0.0046	CcSEcCtD
WF10—Hyponatraemia—Vincristine—hematologic cancer	0.000488	0.00455	CcSEcCtD
WF10—Oedema—Mercaptopurine—hematologic cancer	0.000483	0.0045	CcSEcCtD
WF10—Oedema—Clofarabine—hematologic cancer	0.000477	0.00444	CcSEcCtD
WF10—Oedema—Daunorubicin—hematologic cancer	0.000477	0.00444	CcSEcCtD
WF10—Hyponatraemia—Mitoxantrone—hematologic cancer	0.000475	0.00443	CcSEcCtD
WF10—Hyponatraemia—Irinotecan—hematologic cancer	0.000475	0.00443	CcSEcCtD
WF10—Oedema—Anagrelide—hematologic cancer	0.000474	0.00442	CcSEcCtD
WF10—Infection—Clofarabine—hematologic cancer	0.000473	0.00441	CcSEcCtD
WF10—Infection—Daunorubicin—hematologic cancer	0.000473	0.00441	CcSEcCtD
WF10—Infection—Pentostatin—hematologic cancer	0.000471	0.00439	CcSEcCtD
WF10—Infection—Anagrelide—hematologic cancer	0.000471	0.00439	CcSEcCtD
WF10—Lung disorder—Methotrexate—hematologic cancer	0.000459	0.00428	CcSEcCtD
WF10—Phlebitis—Etoposide—hematologic cancer	0.000457	0.00426	CcSEcCtD
WF10—Infection—Idarubicin—hematologic cancer	0.000455	0.00423	CcSEcCtD
WF10—Oedema—Teniposide—hematologic cancer	0.000445	0.00415	CcSEcCtD
WF10—Infection—Teniposide—hematologic cancer	0.000442	0.00412	CcSEcCtD
WF10—Hyponatraemia—Cisplatin—hematologic cancer	0.000432	0.00402	CcSEcCtD
WF10—Lung disorder—Epirubicin—hematologic cancer	0.00043	0.004	CcSEcCtD
WF10—Oedema—Busulfan—hematologic cancer	0.000412	0.00384	CcSEcCtD
WF10—Infection—Busulfan—hematologic cancer	0.00041	0.00382	CcSEcCtD
WF10—Body temperature increased—Nelarabine—hematologic cancer	0.000403	0.00375	CcSEcCtD
WF10—Oedema—Procarbazine—hematologic cancer	0.0004	0.00373	CcSEcCtD
WF10—Lung disorder—Doxorubicin—hematologic cancer	0.000398	0.0037	CcSEcCtD
WF10—Infection—Procarbazine—hematologic cancer	0.000398	0.0037	CcSEcCtD
WF10—Body temperature increased—Methoxsalen—hematologic cancer	0.000393	0.00366	CcSEcCtD
WF10—Oedema—Bexarotene—hematologic cancer	0.000392	0.00365	CcSEcCtD
WF10—Oedema—Dasatinib—hematologic cancer	0.000392	0.00365	CcSEcCtD
WF10—Oedema—Fludarabine—hematologic cancer	0.000391	0.00364	CcSEcCtD
WF10—Infection—Bexarotene—hematologic cancer	0.00039	0.00363	CcSEcCtD
WF10—Infection—Dasatinib—hematologic cancer	0.00039	0.00363	CcSEcCtD
WF10—Infection—Fludarabine—hematologic cancer	0.000389	0.00362	CcSEcCtD
WF10—Body temperature increased—Mercaptopurine—hematologic cancer	0.000382	0.00356	CcSEcCtD
WF10—Body temperature increased—Daunorubicin—hematologic cancer	0.000377	0.00351	CcSEcCtD
WF10—Body temperature increased—Clofarabine—hematologic cancer	0.000377	0.00351	CcSEcCtD
WF10—Body temperature increased—Pentostatin—hematologic cancer	0.000375	0.00349	CcSEcCtD
WF10—Body temperature increased—Anagrelide—hematologic cancer	0.000375	0.00349	CcSEcCtD
WF10—Extravasation—Methotrexate—hematologic cancer	0.000372	0.00347	CcSEcCtD
WF10—Infection—Chlorambucil—hematologic cancer	0.000368	0.00343	CcSEcCtD
WF10—Oedema—Nilotinib—hematologic cancer	0.000362	0.00338	CcSEcCtD
WF10—Body temperature increased—Idarubicin—hematologic cancer	0.000362	0.00337	CcSEcCtD
WF10—Oedema—Imatinib—hematologic cancer	0.00036	0.00336	CcSEcCtD
WF10—Infection—Nilotinib—hematologic cancer	0.00036	0.00335	CcSEcCtD
WF10—Infection—Imatinib—hematologic cancer	0.000358	0.00333	CcSEcCtD
WF10—Oedema—Cladribine—hematologic cancer	0.000354	0.0033	CcSEcCtD
WF10—Body temperature increased—Teniposide—hematologic cancer	0.000352	0.00328	CcSEcCtD
WF10—Infection—Cladribine—hematologic cancer	0.000352	0.00328	CcSEcCtD
WF10—Extravasation—Epirubicin—hematologic cancer	0.000349	0.00325	CcSEcCtD
WF10—Body temperature increased—Busulfan—hematologic cancer	0.000326	0.00304	CcSEcCtD
WF10—Oedema—Melphalan—hematologic cancer	0.000323	0.00301	CcSEcCtD
WF10—Extravasation—Doxorubicin—hematologic cancer	0.000323	0.003	CcSEcCtD
WF10—Infection—Melphalan—hematologic cancer	0.000321	0.00299	CcSEcCtD
WF10—Body temperature increased—Procarbazine—hematologic cancer	0.000316	0.00295	CcSEcCtD
WF10—Oedema—Lenalidomide—hematologic cancer	0.000314	0.00293	CcSEcCtD
WF10—Infection—Lenalidomide—hematologic cancer	0.000312	0.00291	CcSEcCtD
WF10—Body temperature increased—Bexarotene—hematologic cancer	0.00031	0.00289	CcSEcCtD
WF10—Body temperature increased—Dasatinib—hematologic cancer	0.00031	0.00289	CcSEcCtD
WF10—Oedema—Hydroxyurea—hematologic cancer	0.00031	0.00288	CcSEcCtD
WF10—Body temperature increased—Fludarabine—hematologic cancer	0.000309	0.00288	CcSEcCtD
WF10—Infection—Hydroxyurea—hematologic cancer	0.000308	0.00287	CcSEcCtD
WF10—Body temperature increased—Chlorambucil—hematologic cancer	0.000293	0.00273	CcSEcCtD
WF10—Oedema—Bortezomib—hematologic cancer	0.000289	0.00269	CcSEcCtD
WF10—Infection—Bortezomib—hematologic cancer	0.000287	0.00267	CcSEcCtD
WF10—Oedema—Bleomycin—hematologic cancer	0.000287	0.00267	CcSEcCtD
WF10—Body temperature increased—Nilotinib—hematologic cancer	0.000286	0.00267	CcSEcCtD
WF10—Infection—Bleomycin—hematologic cancer	0.000285	0.00265	CcSEcCtD
WF10—Body temperature increased—Imatinib—hematologic cancer	0.000285	0.00265	CcSEcCtD
WF10—Infection—Vinorelbine—hematologic cancer	0.00028	0.00261	CcSEcCtD
WF10—Body temperature increased—Cladribine—hematologic cancer	0.00028	0.00261	CcSEcCtD
WF10—Infection—Thiotepa—hematologic cancer	0.000268	0.00249	CcSEcCtD
WF10—Oedema—Thalidomide—hematologic cancer	0.000261	0.00243	CcSEcCtD
WF10—Infection—Thalidomide—hematologic cancer	0.000259	0.00241	CcSEcCtD
WF10—Phlebitis—Epirubicin—hematologic cancer	0.000256	0.00239	CcSEcCtD
WF10—Oedema—Carmustine—hematologic cancer	0.00025	0.00233	CcSEcCtD
WF10—Infection—Carmustine—hematologic cancer	0.000249	0.00232	CcSEcCtD
WF10—Body temperature increased—Lenalidomide—hematologic cancer	0.000248	0.00231	CcSEcCtD
WF10—Oedema—Alitretinoin—hematologic cancer	0.000248	0.00231	CcSEcCtD
WF10—Infection—Alitretinoin—hematologic cancer	0.000246	0.0023	CcSEcCtD
WF10—Oedema—Ifosfamide—hematologic cancer	0.000245	0.00228	CcSEcCtD
WF10—Body temperature increased—Hydroxyurea—hematologic cancer	0.000245	0.00228	CcSEcCtD
WF10—Infection—Ifosfamide—hematologic cancer	0.000243	0.00227	CcSEcCtD
WF10—Oedema—Vincristine—hematologic cancer	0.000239	0.00223	CcSEcCtD
WF10—Infection—Vincristine—hematologic cancer	0.000237	0.00221	CcSEcCtD
WF10—Phlebitis—Doxorubicin—hematologic cancer	0.000237	0.00221	CcSEcCtD
WF10—Oedema—Mitoxantrone—hematologic cancer	0.000233	0.00217	CcSEcCtD
WF10—Oedema—Irinotecan—hematologic cancer	0.000233	0.00217	CcSEcCtD
WF10—Infection—Mitoxantrone—hematologic cancer	0.000231	0.00215	CcSEcCtD
WF10—Infection—Irinotecan—hematologic cancer	0.000231	0.00215	CcSEcCtD
WF10—Body temperature increased—Bortezomib—hematologic cancer	0.000228	0.00213	CcSEcCtD
WF10—Body temperature increased—Bleomycin—hematologic cancer	0.000227	0.00211	CcSEcCtD
WF10—Oedema—Gemcitabine—hematologic cancer	0.000227	0.00211	CcSEcCtD
WF10—Infection—Gemcitabine—hematologic cancer	0.000225	0.0021	CcSEcCtD
WF10—Body temperature increased—Vinorelbine—hematologic cancer	0.000223	0.00208	CcSEcCtD
WF10—Hyponatraemia—Epirubicin—hematologic cancer	0.000222	0.00206	CcSEcCtD
WF10—Body temperature increased—Thiotepa—hematologic cancer	0.000213	0.00198	CcSEcCtD
WF10—Oedema—Cisplatin—hematologic cancer	0.000211	0.00197	CcSEcCtD
WF10—Infection—Cisplatin—hematologic cancer	0.00021	0.00196	CcSEcCtD
WF10—Body temperature increased—Thalidomide—hematologic cancer	0.000206	0.00192	CcSEcCtD
WF10—Hyponatraemia—Doxorubicin—hematologic cancer	0.000205	0.00191	CcSEcCtD
WF10—Body temperature increased—Carmustine—hematologic cancer	0.000198	0.00184	CcSEcCtD
WF10—Body temperature increased—Alitretinoin—hematologic cancer	0.000196	0.00183	CcSEcCtD
WF10—Body temperature increased—Ifosfamide—hematologic cancer	0.000194	0.0018	CcSEcCtD
WF10—Infection—Etoposide—hematologic cancer	0.000192	0.00179	CcSEcCtD
WF10—Oedema—Prednisolone—hematologic cancer	0.000191	0.00178	CcSEcCtD
WF10—Body temperature increased—Vincristine—hematologic cancer	0.000189	0.00176	CcSEcCtD
WF10—Body temperature increased—Mitoxantrone—hematologic cancer	0.000184	0.00171	CcSEcCtD
WF10—Body temperature increased—Irinotecan—hematologic cancer	0.000184	0.00171	CcSEcCtD
WF10—Body temperature increased—Gemcitabine—hematologic cancer	0.000179	0.00167	CcSEcCtD
WF10—Oedema—Triamcinolone—hematologic cancer	0.000176	0.00164	CcSEcCtD
WF10—Infection—Triamcinolone—hematologic cancer	0.000174	0.00162	CcSEcCtD
WF10—Body temperature increased—Cisplatin—hematologic cancer	0.000167	0.00156	CcSEcCtD
WF10—Oedema—Dexamethasone—hematologic cancer	0.000159	0.00148	CcSEcCtD
WF10—Oedema—Betamethasone—hematologic cancer	0.000159	0.00148	CcSEcCtD
WF10—Infection—Dexamethasone—hematologic cancer	0.000158	0.00147	CcSEcCtD
WF10—Infection—Betamethasone—hematologic cancer	0.000158	0.00147	CcSEcCtD
WF10—Body temperature increased—Etoposide—hematologic cancer	0.000153	0.00143	CcSEcCtD
WF10—Body temperature increased—Triamcinolone—hematologic cancer	0.000139	0.00129	CcSEcCtD
WF10—Oedema—Prednisone—hematologic cancer	0.000139	0.00129	CcSEcCtD
WF10—Infection—Prednisone—hematologic cancer	0.000138	0.00128	CcSEcCtD
WF10—Body temperature increased—Dexamethasone—hematologic cancer	0.000126	0.00117	CcSEcCtD
WF10—Body temperature increased—Betamethasone—hematologic cancer	0.000126	0.00117	CcSEcCtD
WF10—Infection—Methotrexate—hematologic cancer	0.000115	0.00107	CcSEcCtD
WF10—Body temperature increased—Prednisone—hematologic cancer	0.00011	0.00102	CcSEcCtD
WF10—Oedema—Epirubicin—hematologic cancer	0.000109	0.00101	CcSEcCtD
WF10—Infection—Epirubicin—hematologic cancer	0.000108	0.001	CcSEcCtD
WF10—Oedema—Doxorubicin—hematologic cancer	0.0001	0.000935	CcSEcCtD
WF10—Infection—Doxorubicin—hematologic cancer	9.97e-05	0.000929	CcSEcCtD
WF10—Body temperature increased—Methotrexate—hematologic cancer	9.17e-05	0.000854	CcSEcCtD
WF10—Body temperature increased—Epirubicin—hematologic cancer	8.58e-05	0.000799	CcSEcCtD
WF10—Body temperature increased—Doxorubicin—hematologic cancer	7.94e-05	0.000739	CcSEcCtD
